(Charlotte/Quebec, November 12, 2020) Dentists now have the opportunity to use Primescan in a new area of application: Obstructive Sleep Apnea (OSA) and snoring, which affects up to 3.61 billion …
News
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history
The Fund continues the proven “Project Focused Company” investment strategy for early-stage drug development candidates. In addition, the Fund continues to invest in late-stage clinical …
CENTOGENE Announces Leadership Transition
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …
2022 TVM Capital Winter Conference
Dear Friends and Partners of TVM Capital Life Science. In light of the ongoing (COVID-19) coronavirus outbreak and the resulting travel restrictions, we have decided to postpone the TVM Winter …
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …